Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrystal Amber Regulatory News (CRS)

Share Price Information for Crystal Amber (CRS)

Share Price is delayed by 15 minutes
Get Live Data
104.00    0.00 (0.00%)
Bid:
102.00
Ask:
106.00
Spread: 4.00 (3.922%)
Market Cap: £61.92m
CRS Live PriceLast checked at - London Stock Exchange

Intraday Crystal Amber Share Chart

Statement regarding Northgate plc (“Northgate”)

29 Mar 2019 16:32

Crystal Amber Fund Limited - Statement regarding Northgate plc (“Northgate”)

Crystal Amber Fund Limited - Statement regarding Northgate plc (“Northgate”)

PR Newswire

London, March 29

29 March 2019

CRYSTAL AMBER FUND LIMITED

(“Crystal Amber Fund” or the “Fund”)

Statement regarding Northgate plc (“Northgate”)

Crystal Amber Fund notes and welcomes yesterday’s announcement from Northgate that its Chairman, Andrew Page, had resigned from the board with immediate effect.

On 11 March 2019, the Fund wrote to Northgate requisitioning a general meeting of shareholders to seek the removal of Andrew Page and the appointment of a new, independent director, Steve Smith.

As a result of Andrew Page’s resignation and the focus on the search for a new Chairman, the Fund has today written to Northgate withdrawing its requisition of a general meeting of shareholders.

The Fund looks forward to Northgate identifying and appointing a new Chairman, ideally with relevant industry experience, who will be focused on delivering the best outcome for Northgate’s stakeholders, including recognising and being open to releasing Northgate’s strategic value.

The Fund expects the board of Northgate to consult with its shareholders regarding this important appointment.

For further enquiries please contact:

Crystal Amber Fund Limited
Christopher Waldron (Chairman)Tel: 01481 742 742
Allenby Capital Limited - Nominated Adviser
David Worlidge/Liz KirchnerTel: 020 3328 5656
Winterflood Investment Trusts - Broker
Joe Winkley/Neil LangfordTel: 020 3100 0160
Crystal Amber Advisers (UK) LLP - Investment Adviser
Richard BernsteinTel: 020 7478 9080
Date   Source Headline
16th Aug 20249:45 amRNSDirector/PDMR Shareholding
16th Aug 20249:43 amRNSTransaction in Own Shares and Total Voting Rights
15th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Aug 20247:00 amRNSExtension to Share Buyback Programme
31st Jul 20245:00 pmRNSTotal Voting Rights
31st Jul 202411:50 amRNSInvestee company update: Morphic Medical Inc.
31st Jul 202411:07 amRNSMonthly Net Asset Value
26th Jul 20244:06 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jul 20246:04 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jul 20245:42 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jun 20245:15 pmRNSTotal Voting Rights
21st Jun 20245:00 pmRNSTransaction in Own Shares and Total Voting Rights
19th Jun 202410:07 amRNSMonthly Net Asset Value
18th Jun 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jun 20244:49 pmRNSTransaction in Own Shares and Total Voting Rights
6th Jun 20245:15 pmRNSTransaction in Own Shares and Total Voting Rights
5th Jun 20245:43 pmRNSTransaction in Own Shares and Total Voting Rights
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 202412:11 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNSMorphic Medical – FDA approval of study amendments
3rd Jun 20245:33 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 20245:39 pmRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
23rd May 20241:21 pmRNSMonthly Net Asset Value
23rd May 20247:00 amRNSExtension to Share Buyback Programme
22nd May 20247:00 amRNSTransaction in Own Shares
17th May 20245:49 pmRNSTransaction in Own Shares
3rd May 20246:22 pmRNSHolding(s) in Company
2nd May 202412:37 pmRNSHolding(s) in Company
1st May 20245:22 pmRNSTransaction in Own Shares
30th Apr 20245:37 pmRNSTotal Voting Rights
29th Apr 20243:26 pmRNSHolding(s) in Company
26th Apr 20245:27 pmRNSTransaction in Own Shares
25th Apr 20247:00 amRNSHolding(s) in Company
24th Apr 20244:00 pmRNSMonthly Net Asset Value
24th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20246:22 pmRNSTransaction in Own Shares
10th Apr 20249:34 amRNSTransaction in Own Shares
3rd Apr 20244:44 pmRNSMonthly Net Asset Value
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:30 pmRNSExtension to Share Buyback Programme
28th Mar 20246:01 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20246:27 pmRNSTransaction in Own Shares
22nd Mar 20245:09 pmRNSTransaction in Own Shares
18th Mar 20245:29 pmRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20245:30 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.